ORIGINAL RESEARCH ARTICLE
Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine

https://doi.org/10.1016/j.msard.2021.103113Get rights and content

HIGHLIGHTS

  • Patients older than 50 years felt their clinical support reduced during the pandemic.

  • 48.9% would like to be vaccinated, 39.2% were unsure and 11.9% would refuse the vaccine.

  • Patients with progressive MS fear an MS aggravation if they are vaccinated for COVID-19.

  • Fears and expectations towards vaccination must be discussed with pwMS.

  • Knowing pwMS’ opinions on COVID-19 impact and vaccination is useful to better address these issues.

ABSTRACT

BACKGROUND

Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS’ beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS’ opinions on general vaccination.

METHODS

Observational study, based on a cross-sectional (10-20th September 2020) online survey, conducted in a cohort of pwMS’ followed at two Portuguese hospitals. The survey included measures to characterize the sample and a questionnaire designed to assess the topics defined for this study.

RESULTS

270 respondents completed the full survey (response rate 58.2%). pwMS greatest concern during the pandemic was an aggravation of MS, especially by patients older than 50 years old. Almost 40% of the patients older than 50 felt that the pandemic negatively affected their MS related medical assistance. Most patients believed they would recover from COVID-19 infection. More than half of the responders feared a MS aggravation if they got COVID-19; this was more pronounced in patients with progressive MS. About 12% of the participants did not want to be vaccinated and almost 40% was unsure. Regarding vaccines in general, almost a third of the participants feared their side effects or MS related complications.

CONCLUSION

Having knowledge of pwMS’ opinions on COVID-19 pandemic impact and vaccination is useful to better address these issues. Fears and expectations towards vaccination must be discussed with pwMS.

KEYWORDS

multiple sclerosis
COVID-19 pandemic
vaccines
opinions
questionnaire

Abbreviations

MS
multiple sclerosis
CNS
central nervous system
PwMS
people with multiple sclerosis
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
COVID-19
coronavirus disease of 2019
DMT
disease modifying therapy
CIS
clinically isolated syndrome
RRMS
relapse-remitting MS
PPMS
primary progressive MS
SPMS
secondary progressive MS
OD
odds ratio
CI
confidence interval

Cited by (0)

View Abstract